Prostate Cancer Upgrading Reference Set

Korábbi kezelés

• Gleason score greater than 3+3 on any prior prostate biopsy.
• Prior treatment of the prostate with androgen deprivation, radiation, or other cytotoxic chemotherapy.

Más betegség

• Any treatment other than radical prostatectomy planned for prostate cancer.

• Prostate cancer, confirmed on prostate biopsy, within two years of scheduled radical prostatectomy.
• Prostate cancer must be graded as Gleason 3+3 on the biopsy immediately prior to radical prostatectomy. (Secondary eligibility will be established on central review of pathology slides, and blocks if available, at Cornell Central Pathology Laboratory to confirm eligibility.)
• Prostate cancer may have been detected on prior biopsy as well but must not be greater than Gleason 3+3. (Also requires Central Pathology Laboratory review.)
• Slides must be available for Central Pathology Laboratory review on any biopsy showing prostate cancer. FFPE Blocks may also be requested if available.
• Patient must have selected radical prostatectomy as treatment for prostate cancer.
• Signed informed consent.
• Blocks and/or slides from prostate biopsy and from radical prostatectomy must be available for analysis by Central Pathology laboratory.
• Willingness to provide long-term follow-up information regarding additional treatments and cancer status.
• Willingness to provide blood and urine specimens prior to radical prostatectomy for placement in the EDRN Upgrading Reference Set repository.
• Willingness to provide demographic and clinical information related to prostate cancer and prostate cancer risk (e.g., race/ethnicity, family history of prostate cancer).